SIMPAS

Technology

Last mentioned: Mar 17, 2026

Timeline

  1. Earnings Call

    Official earnings release and investor conference call held.

  2. SEC Filing

    Company files FY 2025 results with the SEC.

  3. SIMPAS Expansion

    Record adoption of SIMPAS technology during the peak U.S. growing season.

  4. Q1 Stabilization

    North American inventory levels stabilize following the 2024 destocking cycle.

  5. Transformation Launch

    AVD initiates a business transformation program to save $15M annually.

Stories mentioning SIMPAS 2

pharma Neutral

American Vanguard (AVD) Reports FY 2025 Results, Citing Transformation Success

American Vanguard (NYSE: AVD) reported its full-year 2025 financial results, highlighting a return to growth following a period of strategic restructuring and inventory destocking in the global agricultural sector. The company emphasized the expansion of its 'Green Solutions' biological portfolio and the successful implementation of its business transformation initiative.

3 sources
earnings Neutral

American Vanguard Completes 2025 Transformation with Strong Full-Year Results

American Vanguard (AVD) has reported its full-year 2025 financial results, marking the successful conclusion of its multi-year business transformation plan. The company achieved significant margin expansion and realized its $15 million cost-savings target, signaling a definitive recovery from the agrochemical industry's recent inventory cycles.

3 sources